Profil bibliographique

Yara Abdou

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées

1Citations signalées

4Affiliations récentes

Institutions déclarées

University of North Carolina at Chapel Hill University of North Carolina Hospitals Molecular Oncology (United States)UNC Lineberger Comprehensive Cancer Center

Domaines associés

Breast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers

Publications récentes

Accès ouvert 2026 articleOpenAlex

CLTR-10 PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES (SOLARA)

Colette Shen, Yara Abdou, Linda Chen, Mina Lobbous et autres

0 citationsNeuro-Oncology Advances

Accès ouvert 2026 articleOpenAlex

Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non–Small Cell Lung Cancer

Gebra Cuyún Carter, Snehal G. Thakkar, David Gandara, Katalin Bognar et autres

0 citationsUNC Libraries

2026 articleOpenAlex

Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007)

Yara Abdou, Jess Hoag, William E. Barlow, Kathy S. Albain et autres

1 citationJNCI Journal of the National Cancer Institute

Accès ouvert 2026 preprintOpenAlex

MRI-based Prognostic Model in Early-Stage HR+/HER2- Breast Cancer

Poornima Saha, Frederick Howard, Erica Stringer‐Reasor, Yara Abdou et autres

0 citationsResearch Square

Accès ouvert 2026 conference-abstractOpenAlex

PREDICT-RD: Postoperative molecular residual disease by ctDNA surveillance in TNBC with residual disease (TBCRC-071).

Yara Abdou, Naim Rashid, Katherine E. Reeder‐Hayes, Allison Camp et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Primary results from the triple-negative cohort of TBCRC-053 (P-RAD): A randomized trial of no, low, or high dose preoperative radiation with pembrolizumab and chemotherapy in node-positive breast cancer.

Alice Yoosun Ho, Laura Spring, Faeze Gharibpoor, Rachel Catherine Blitzblau et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)

Yara Abdou, Mariya Rozenblit, Dario Trapani, Ioannis Zerdes et autres

0 citationsnpj Breast Cancer

Accès ouvert 2026 reviewOpenAlex

Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies

Silvio Matsas, Julita Zembala, Anderson Ruiz Simões, Luiza Giuliani Schmitt et autres

0 citationsAsian Pacific Journal of Cancer Prevention

Accès ouvert 2026 articleOpenAlex

Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer

Emily C. Huber, G. Gupta, Ryan Morse, Yara Abdou et autres

0 citationsBreast Cancer Research and Treatment

Accès ouvert 2026 datasetOpenAlex

Data Management and Sharing Plan for: PREDICT-RD: Postoperative Molecular Residual Disease by ctDNA Surveillance in TNBC with Residual Disease

Yara Abdou

0 citationsUNC Dataverse

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.